Azapropazone (Prolixan)
Helleberg, L.
Ugeskrift for Laeger 143(20): 1286-1287
1981
ISSN/ISBN: 0041-5782 PMID: 7292688 Document Number: 172421
Document emailed within 1 workday
Related Documents
Faust-Tinnefeldt, G.F.; Geissler, H.E. 1978: Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone Arzneimittel-Forschung 28(2): 337-341Beeley, L. 1991: Azapropazone and warfarin Bmj 302(6788): 1341
Gikalov, I.; Kaufmann, R.; Schuster, O. 1982: Human pharmacokinetics of different I.v. doses of azapropazone (HPLC-determination) Arzneimittel-Forschung 32(4): 423-426
Fenner, H.; Mixich, G. 1973: NMR studies on the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation Arzneimittel-Forschung 23(5): 667-669
Geissler, H.E.; Mutschler, E.; Faust-Tinnefeldt, G. 1977: On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography Arzneimittel-Forschung 27(9): 1713-1715
Templeton, J.S. 1982: Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report British Journal of Clinical Practice 36(10): 353-358
Faust-Tinnefeldt, G.; Geissler, H.E.; Mutschler, E. 1977: Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents Arzneimittel-Forschung 27(11): 2153-2157
Schrüffer, H.; Stein, W. 1979: A double-blind comparative study of the analgesic effect of Azapropazone, alone or in combination with dextropropoxyphen Schweizerische Rundschau für Medizin Praxis 68(29): 950-957
Farrier, D.S. 1974: Spectroscopic methods for the determination of azapropazone in serum developed and evaluated using radio-isotopic techniques Arzneimittel-Forschung 24(5): 747-751